Papillomatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Clinical Trials

Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Condition:   Recurrent Respiratory PapillomatosisInterventions:   Drug: celebrex (celecoxib);   Drug: placebo capsulesSponsors:   North Shore Long Island Jewish Health System;   National Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2007 Category: Research Source Type: clinical trials

Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Condition:   Recurrent Respiratory PapillomatosisInterventions:   Drug: celebrex (celecoxib);   Drug: placebo capsulesSponsors:   North Shore Long Island Jewish Health System;   National Institute on Deafness and Other Communication Disorders (NIDCD)Completed - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2007 Category: Research Source Type: clinical trials

Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Condition:   Recurrent Respiratory PapillomatosisInterventions:   Drug: celebrex (celecoxib);   Drug: placebo capsulesSponsors:   North Shore Long Island Jewish Health System;   National Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2007 Category: Research Source Type: clinical trials